Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

NASDAQ:SBC - Nasdaq - US73245B1070 - Common Stock - Currency: USD

5.11  +0.27 (+5.47%)

Fundamental Rating

6

Overall SBC gets a fundamental rating of 6 out of 10. We evaluated SBC against 102 industry peers in the Health Care Providers & Services industry. While SBC has a great health rating, its profitability is only average at the moment. SBC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SBC was profitable.
In the past year SBC had a positive cash flow from operations.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

SBC has a better Return On Assets (17.34%) than 97.06% of its industry peers.
SBC has a better Return On Equity (21.80%) than 88.24% of its industry peers.
SBC has a better Return On Invested Capital (28.47%) than 97.06% of its industry peers.
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROIC 28.47%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 24.94%, SBC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Operating Margin value of 43.00%, SBC belongs to the best of the industry, outperforming 99.02% of the companies in the same industry.
Looking at the Gross Margin, with a value of 77.94%, SBC belongs to the top of the industry, outperforming 93.14% of the companies in the same industry.
Industry RankSector Rank
OM 43%
PM (TTM) 24.94%
GM 77.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SBC is creating value.
The number of shares outstanding for SBC has been reduced compared to 1 year ago.
Compared to 1 year ago, SBC has an improved debt to assets ratio.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SBC has an Altman-Z score of 8.88. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
SBC has a Altman-Z score of 8.88. This is amongst the best in the industry. SBC outperforms 94.12% of its industry peers.
SBC has a debt to FCF ratio of 0.56. This is a very positive value and a sign of high solvency as it would only need 0.56 years to pay back of all of its debts.
SBC's Debt to FCF ratio of 0.56 is amongst the best of the industry. SBC outperforms 90.20% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that SBC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.03, SBC belongs to the top of the industry, outperforming 81.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Altman-Z 8.88
ROIC/WACC3.23
WACC8.82%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 4.44 indicates that SBC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.44, SBC belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
SBC has a Quick Ratio of 4.40. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.40, SBC belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.44
Quick Ratio 4.4
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 383.61% over the past year.
Looking at the last year, SBC shows a very strong growth in Revenue. The Revenue has grown by 261.14%.
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%

3.2 Future

SBC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.24% yearly.
The Revenue is expected to grow by 1.15% on average over the next years.
EPS Next Y-24.37%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.84%
Revenue Next 2Y1.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.11, which indicates a very decent valuation of SBC.
88.24% of the companies in the same industry are more expensive than SBC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, SBC is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.13, the valuation of SBC can be described as very cheap.
Based on the Price/Forward Earnings ratio, SBC is valued cheaply inside the industry as 95.10% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.06. SBC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.11
Fwd PE 7.13
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SBC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SBC is cheaper than 94.12% of the companies in the same industry.
SBC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.45
EV/EBITDA 4.59
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.24%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (6/5/2025, 8:08:17 PM)

5.11

+0.27 (+5.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)09-21 2025-09-21
Inst Owners0.04%
Inst Owner ChangeN/A
Ins Owners90.25%
Ins Owner Change0%
Market Cap529.45M
AnalystsN/A
Price Target6.12 (19.77%)
Short Float %0.31%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.84%
Min EPS beat(2)10.66%
Max EPS beat(2)89.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.84%
Min Revenue beat(2)-22.64%
Max Revenue beat(2)-9.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-45.45%
EPS NQ rev (1m)-6.25%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)-32.33%
EPS NY rev (3m)-36.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-29.13%
Revenue NY rev (1m)-8.54%
Revenue NY rev (3m)-23.11%
Valuation
Industry RankSector Rank
PE 11.11
Fwd PE 7.13
P/S 2.67
P/FCF 34.45
P/OCF 28.12
P/B 2.34
P/tB 2.41
EV/EBITDA 4.59
EPS(TTM)0.46
EY9%
EPS(NY)0.72
Fwd EY14.03%
FCF(TTM)0.15
FCFY2.9%
OCF(TTM)0.18
OCFY3.56%
SpS1.91
BVpS2.19
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.34%
ROE 21.8%
ROCE 36.04%
ROIC 28.47%
ROICexc 64.59%
ROICexgc 68.77%
OM 43%
PM (TTM) 24.94%
GM 77.94%
FCFM 7.76%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.56
Debt/EBITDA 0.08
Cap/Depr 101.52%
Cap/Sales 1.75%
Interest Coverage 2701.71
Cash Conversion 21.27%
Profit Quality 31.14%
Current Ratio 4.44
Quick Ratio 4.4
Altman-Z 8.88
F-Score6
WACC8.82%
ROIC/WACC3.23
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)383.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.16%
EPS Next Y-24.37%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)261.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-13.65%
Revenue Next Year-9.84%
Revenue Next 2Y1.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y268.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1908.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2315.21%
OCF growth 3YN/A
OCF growth 5YN/A